Chase Investment Counsel Corp Vertex Pharmaceuticals Inc Transaction History

Chase Investment Counsel Corp

$296 Million
Q3 2024

A detailed history of Chase Investment Counsel Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 7,063 shares of VRTX stock, worth $3.41 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

7,063

Previous 8,248 14.37%

Holding current value

$3.41 Million

Previous $3.87 Million 15.05%

% of portfolio

1.11%

Previous 1.38%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$460.0 - $505.78 $545,100 - $599,349	-1,185 Reduced 14.37%	7,063 $3.28 Million
Q2 2024 Aug 02, 2024	BUY	$392.81 - $485.53 $56,957 - $70,401	145 Added 1.79%	8,248 $3.87 Million
Q1 2024 May 02, 2024	BUY	$407.69 - $446.08 $554,050 - $606,222	1,359 Added 20.15%	8,103 $3.39 Million
Q4 2023 Feb 05, 2024	SELL	$343.0 - $410.68 $149,548 - $179,056	-436 Reduced 6.07%	6,744 $2.74 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $18,599 - $19,935	55 Added 0.77%	7,180 $2.5 Million
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $45,276 - $50,675	144 Added 2.06%	7,125 $2.51 Million
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $22,658 - $25,848	80 Added 1.16%	6,981 $2.2 Million
Q4 2022 Jan 25, 2023	SELL	$285.76 - $321.48 $1.3 Million - $1.46 Million	-4,535 Reduced 39.66%	6,901 $1.99 Million
Q3 2022 Oct 31, 2022	BUY	$273.83 - $305.53 $830,800 - $926,978	3,034 Added 36.11%	11,436 $3.31 Million
Q2 2022 Jul 26, 2022	BUY	$234.96 - $292.55 $1.97 Million - $2.46 Million	8,402 New	8,402 $2.37 Million
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $2.35 Million - $3.14 Million	-11,375 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $482,155 - $571,646	-1,886 Reduced 14.22%	11,375 $3.1 Million
Q2 2020 Aug 05, 2020	SELL	$225.48 - $295.8 $681,400 - $893,907	-3,022 Reduced 18.56%	13,261 $3.85 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $3.25 Million - $4.04 Million	16,283 New	16,283 $3.87 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Account

Chase Investment Counsel Corp Vertex Pharmaceuticals Inc Transaction History